CCR5-Δ32 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

888 results for “CCR5-Δ32”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

CCR5-blockade in Metastatic Colorectal Cancer

12 participants · First posted Nov 29, 2012

CCR5-modified CD4+ T Cells for HIV Infection

30 participants · First posted Sep 12, 2018

Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

97 participants · First posted Apr 18, 2016

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

32 participants · First posted Jun 22, 2009

Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes

3 participants · First posted May 9, 2014

Active, not recruiting

CD4 CAR+ ZFN-modified T Cells in HIV Therapy

12 participants · First posted Aug 6, 2018

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

First posted Feb 16, 2023

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

22 participants · First posted Dec 6, 2018

Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)

68 participants · First posted Mar 18, 2009

Active, not recruiting

CLOVER - CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen

66 participants · First posted Nov 21, 2024

Page 1 of 50